All news
Medium ImpactPharma

Natco Pharma invests in US biotech eGenesis Inc

Natco Pharma invests in US biotech eGenesis Inc. The company announced a strategic investment in eGenesis, Inc., a Massachusetts-based biotech firm, to explore cutting-edge biopharma opportunities. This move aims to strengthen Natco’s global footprint in advanced therapeutics. Financial details were not disclosed.

📊 STOCKS: $NATCOPHARM | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #Investment

#Investment#Biotech#Innovation
This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.